Inventor
Bennett C. Borer
Inventor
San Diego, CA, US
Overview
Patents· 13 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds35%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
A61KPreparations for medical, dental or toiletry purposes6%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%
C12NMicroorganisms or enzymes6%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture6%
C12YEnzymes6%
Y02PClimate change mitigation technologies in the production or processing of goods6%
C07BGeneral methods of organic chemistry3%
C07CAcyclic or carbocyclic compounds3%
PatentTitleYear
11,130,757Crystalline forms of MNK inhibitors20219,683,001'Process of producing phosphinothricin employing nitrilases'20178,981,142'Process of producing phosphinothricin employing nitrilases'20157,268,126'Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-ce]indol-6-one'20076,472,534'Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors'20026,465,661'Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors'20026,403,799'Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors'20026,392,067'Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors'20026,316,625'Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors'20016,117,999'Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors'20006,084,107'Intermediates for making HIV-protease inhibitors'20005,925,759'Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors'19995,705,647'Intermediates for making HIV-protease inhibitors'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–2002Patents assigned to AGOURON PHARMA (8)· patent assignee history
1998–2002Patents assigned to JAPAN TOBACCO INC (4)· patent assignee history
1998–2021Based in San Diego, CA, US· patent location history
2000Patents assigned to AGOURON PHRAMACEUTICALS INC (1)· patent assignee history
2002Based in La Jolla, CA, US· patent location history
2015Patents assigned to ALBIZATI KIM F (1)· patent assignee history
2015Patents assigned to BORER BENNETT C (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AGOURON PHARMA | 8 | 1998–2002 |
| JAPAN TOBACCO INC | 4 | 1998–2002 |
| AGOURON PHRAMACEUTICALS INC | 1 | 2000 |
| ALBIZATI KIM F | 1 | 2015 |
| BORER BENNETT Cself | 1 | 2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 10 | 1998–2021 |
| La Jolla, California, US | 3 | 2002 |